Accès au site français Welcome to You buy France The french suppliers portal

SHARE THIS COMPANY

twitter linkedin facebook viadeo

You buy France

IPSEN PHARMA

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2012. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by 3 franchises: neurology, endocrinology and urology-oncology. Moreover, the Group has an active policy of partnerships. Ipsen's R&D is focused on its innovative and differentiated technological platforms, peptides and toxins. In 2012, R&D expenditure totalled close to €250 million, representing more than 20% of Group sales. The Group has close to 4,900 employees worldwide.
Ipsen’s shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the “Service de Règlement Différé” (“SRD”). The Group is part of the SBF 120 index. Ipsen has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trade on the over-the-counter market in the United States under the symbol IPSEY.

[MEMBRE DU CLUB SANTE ALGERIE]

+ Read more

 

Company profile

Related activities :

Health, pharmacy, life sciences

Export area :

European Union

North Asia

Local presence :

C.E.I.

European Union

North Africa

North America

North Asia

Oceania

South America

South-east Asia

Target countries :

North America

More information

Download Company Information

2012 Registration document

Ipsen 2012 registration document

Tags: Registration document

 

Social network

...About

   

 

 

 

 

 

 

 

Business France contributes to the development and success of French and foreign businesses wishing to expand abroad by supporting them throughout the lifetime of their projects, and is driven by an efficient, result-oriented working culture. > Read more

 

Discover the French know how:
   

      

  

Rail industry